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There has been always a large gap between the
number of kidney donors and that of waiting re-
cipients worldwide.1 The shortage of donor organs
can be overcome by increasing the numbers from
living and deceased sources. Nevertheless, deceased
organ availability has reached a plateau and the
demand for organs keeps increasing. In Taiwan,
for example, only 150–200 renal transplantations
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from deceased donors were performed in 2008,
although there were over 6500 patients on the wait-
ing list. Therefore, a resurgence of living donors
is being observed worldwide as a result of the pro-
longed waiting time for deceased donors, avail-
ability of minimally invasive donor nephrectomy
procedures, and significantly better recipient out-
comes with living donor kidney transplantation.
Laparoscopic donor nephrectomy (LDN) was
introduced for living kidney donors by Ratner et al
in 1995.2 In Taiwan, it has been used since 2002.3,4
Benefits of the laparoscopic approach include less
postoperative pain, shorter hospital stays, faster
return to usual activities and work, and improved
cosmesis. Since then, LDN has emerged as the pre-
ferred technique at many institutions, not only in
the United States, but also in other countries.5–12
It has contributed to a dramatic increase in living
kidney donation during the past decade.13,14 The
number of living kidney donations in the United
States exceeded the number of deceased kidney
donations for the first time in 2001, as reported
by the United Network for Organ Sharing.15
We adopted LDN in 2002, with the intention
of increasing the incentives for living kidney do-
nation and maintaining equivalent donor/recipi-
ent outcome with those of previous series and
our open donor nephrectomy (ODN) series.
Methods
Between September 2002 and November 2007,
45 LDNs were performed at the National Cheng
Kung University Hospital. Preoperative donor
evaluation included a medical history review and
physical examination, laboratory studies, histo-
compatibility test and cross-matching, compre-
hensive renal function tests, and psychosocial
evaluation. Renal vascular anatomy of the donors
was evaluated using high-resolution computed to-
mographic angiography with three-dimensional
reconstructions.16,17
The LDN used in this study was derived from
the UCSF (University of California, San Francisco)
method.18 The patient was positioned in a flexed,
modified, lateral decubitus position and pneu-
moperitoneum was achieved using a Veress nee-
dle inserted into the left or right pararectus line.
Three 11-mm and one 12-mm trocars were intro-
duced into the right or left upper abdomen in a
curved L-shape. The 12-mm port was used for in-
troduction of the vascular stapler. Another 11-mm
trocar was inserted through the subxiphoid area
to retract the liver during right LDN. The entire
dissection was completed by a pure laparoscopic
method, and care was taken to preserve generous
amounts of periureteral tissue to minimize disrup-
tion of the ureteral blood supply. Hydration was
given during the whole procedure to maintain ad-
equate urine output. When the kidney was fully
mobilized, the pneumoperitoneum was relaxed
and an 8-cm transverse suprapubic (Pfannenstiel)
incision was made. Intravenous furosemide was
administered while the abdomen was desufflated.
When good diuresis was confirmed, the abdomen
was reinsufflated. The distal ureter was double-
clipped and transected and the patient was system-
ically heparinized.8,9 The renal artery was occluded
using a locking plastic clip (Hem-o-lok clip; Weck
Closure Systems, Research Triangle Park, NC, USA)
and a metal endoclip.19,20 The artery was divided
distal to the clips using laparoscopic scissors. If
there were multiple arteries, each artery arising
from the aorta was occluded with a locking plastic
and a metal clip. The renal vein was stapled using
a 2.5-mm vascular stapler (Endo-TA; US Surgical,
Norwalk, CT, USA) and divided distal to the staple
line using laparoscopic scissors. Heparin sodium
was reversed with protamine sulfate and the 
kidney was removed through the Pfannenstiel
incision.
Donor demographic and operative character-
istics were gathered from patients’ medical records
and analyzed retrospectively. The data included
donor age, gender, donor/recipient relationship,
body height, body weight, body mass index (BMI),
side of the nephrectomy, operative time, estimated
blood loss, need for blood transfusion, renovas-
cular anatomy, warm ischemia time, and length
of postoperative stay. Warm ischemia time was
defined as the time from renal artery occlusion
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to kidney immersion in iced saline solution.
Donor/recipient intraoperative and postoperative
complications were analyzed. Postoperative donor
renal function, graft function, and recipient sur-
vival were also evaluated. Postoperative donor
renal function and immediate/long-term allograft
function were assessed by measurement of serum
creatinine levels. Delayed graft function was de-
fined as the need for dialysis because of poor al-
lograft function within the first postoperative
week.
To determine the trends of both donor and
recipient outcome, the LDN series was divided
into earlier (cases 1–20) and later (cases 21–45)
groups for comparison. To confirm the safety and
efficacy of LDN, we also compared retrospectively
the results between LDN and ODN (12 ODNs
were performed between 1990 and 2001 in our
center).
Statistical analysis
All data were analyzed using SPSS version 11.5
(SPSS Inc, Chicago, IL, USA) for Windows, and
data are expressed as percentages or mean ±
standard error of the mean. Differences among
multiple groups were analyzed using analysis of
variance. Tukey’s HSD test was used as the post
hoc test. Differences between two groups were com-
pared using unpaired Student’s t test. Linear regres-
sion analysis was used to test the independent





The donor demographics of the LDN series are
listed in Table 1. Mean donor age was 42.7 ± 2.1
years (range, 21–77 years), and eight donors
(17.8%) were older than 55 years. Nineteen do-
nors (42.2%) were male and 26 (57.8%) were fe-
male. The relationships of donor/recipient pairs
were first-degree relatives in 46.6%, second-
degree relatives in 26.7%, and spouses in 26.7%
of the series. Mean BMI was 24.3 ± 0.5 (range,
16.6–31.9); 25 donors (55.6%) had a BMI > 24
and eight (17.8%) had a BMI > 27. Donor BMI
did not affect operative time in our series. Mean
human leukocyte antigen mismatch was 2.5 ± 0.3.
Operative characteristics of donors
The donor operative characteristics are listed in
Table 2. Of the 45 consecutive cases, 41 (91.1%)
were left-sided and four (8.9%) were right-sided
LDN. Indications for right nephrectomy were all
left-sided vascular anomalies (multiple renal ar-
teries). All 45 kidneys were procured and trans-
planted successfully with adequate renal artery
and renal vein length. Mean operative time was
327.7 ± 10.2 minutes (range, 220–537 minutes).
Mean estimated blood loss was 286.0 ± 48.3 mL
and four donors (8.9%) required blood transfu-
sion. The mean warm ischemia time was 233.9 ±
19.6 seconds. However, warm ischemia time did
not correlate with incidence of delayed graft func-
tion or recipient serum creatinine levels at any
postoperative time. The mean donor postopera-
tive stay was 5.8 ± 0.2 days. Donor postoperative
stay did not correlate with donor age, gender,
body weight, BMI, operative time, or blood loss.
Forty (88.9%) donors had a single renal artery and
five (11.1%) had multiple renal arteries. There
was a significant increase in intraoperative blood
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Table 1. Donor demographics of the laparoscopic
donor nephrectomy series*





First-degree relative 21 (46.6)
Second-degree relative 12 (26.7)
Spouse 12 (26.7)
Body height (cm) 161.9 ± 1.4
Body weight (kg) 64.0 ± 1.8
Body mass index 24.3 ± 0.5
HLA mismatch no. 2.5 ± 0.3
*Data presented as mean ± standard error of the mean or n (%).
loss in the multiple renal arteries group. Multiple
arteries caused by application of the vascular sta-
pler to a renal artery with early bifurcation were
found in another three donors. Overall, eight
(17.8%) donor kidneys required bench arterial
reconstruction by end-to-side anastomosis of a
smaller polar artery into the main renal artery
(n = 6) or by a double-barrel anastomotic tech-
nique (n = 2).
Donor complications
Intraoperative complications: There were three
renovascular injuries (all to the renal vein). Two
(4.4%) required open conversion and one was
managed laparoscopically. All these cases occurred
in the earlier group (cases 3, 9 and 16). Four (8.9%)
patients required blood transfusion in the peri-
operative period. No operations were aborted and
the nephrectomies were all performed.
Postoperative complications: There were five
cases of lymphatic leakage, one of subcutaneous
bleeding, one abdominal wall abscess (over the
Pfannenstiel incision), and one case of bacteremia.
The overall postoperative complication rate was
17.8%. There were no donor deaths or repeated
surgical procedures. None of the laparoscopic
donors required readmission.
Postoperative donor renal function
The mean preoperative and postoperative serum
creatinine levels of the donors were 0.8 ± 0.0 mg/
dL and 1.2 ± 0.0 mg/dL, respectively. Postoper-
ative serum creatinine level at discharge was 1.5
times (range, 1.1–1.9) preoperative serum creati-
nine level, regardless of donor gender or age
(Table 2).
Recipient outcomes
Immediate graft function: Mean recipient serum
creatinine level was 1.9 ± 0.2 mg/dL at 1 week
postoperatively and 1.4 ± 0.1 mg/dL at discharge.
Recipient postoperative renal function did not cor-
relate significantly with donor age, donor gender,
or preoperative donor renal function. Primary non-
function of the renal allograft did not occur in this
series and delayed graft function occurred in four
of 45 cases (8.9%). The serum creatinine levels of
all the other recipients (91.1%) decreased below
3.0 mg/dL at 1 week postoperatively. Mean recip-
ient postoperative stay was 15.9 ± 1.3 days. All but
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Table 2. Operative characteristics of donors and corresponding donor/recipient outcome in the laparoscopic donor nephrec-
tomy series*
Side of kidney donated Renovascular anatomy
OverallLeft Right Single renal Multiple renal 
nephrectomy nephrectomy artery arteries
Donor 41 (91.1) 4 (8.9) 40 (88.9) 5 (11.1) 45 (100)
Operative time (min) 325.8 ± 11.0 345.5 ± 26.1 318.5 ± 9.6 397.2 ± 39.3 327.7 ± 10.2
Blood loss (mL) 291.0 ± 58.7 237.5 ± 68.8 263.2 ± 43.7 460.0 ± 261.4† 286.0 ± 48.3
Warm ischemia time (s) 232.2 ± 23.6 248.0 ± 52.8 221.2 ± 20.1 341.3 ± 56.1 233.9 ± 19.6
Postoperative stay (d) 5.8 ± 0.2 5.8 ± 0.3 5.8 ± 0.2 5.6 ± 0.2 5.8 ± 0.2
Serum Cr (discharge) (mg/dL) 1.2 ± 0.0 1.2 ± 0.1 1.2 ± 0.0 1.2 ± 0.1 1.2 ± 0.0
Serum Cr ratio 1.5 ± 0.0 1.5 ± 0.2 1.5 ± 0.0 1.5 ± 0.1 1.5 ± 0.0
(discharge/admission)
Recipient
Serum Cr (1 wk) (mg/dL) 1.8 ± 0.3 2.1 ± 0.9 1.9 ± 0.3 1.9 ± 0.7 1.9 ± 0.2
Serum Cr (discharge) (mg/dL) 1.4 ± 0.2 1.4 ± 0.3 1.4 ± 0.1 1.3 ± 0.3 1.4 ± 0.1
Serum Cr (1 yr) (mg/dL) 1.2 ± 0.1 1.6 ± 0.7 1.2 ± 0.1 1.5 ± 0.4 1.3 ± 0.1
*Data presented as n (%) or mean ± standard error of the mean; †p < 0.05 compared with single renal artery group by unpaired Student’s t test.
one patient was discharged with adequate renal
function (serum creatinine < 2.5 mg/dL). No 
recipient mortality occurred in the immediate
postoperative period. Kidneys requiring vascular
reconstruction (n = 8) for multiple renal arteries
experienced the same allograft outcomes as those
without reconstruction (n = 37). The mean serum
creatinine levels of the recipients with and with-
out vascular reconstruction at 1 week postopera-
tively were 1.8 ± 0.5 mg/dL and 1.9 ± 0.3 mg/dL,
respectively (p = not significant). The mean serum
creatinine levels of the recipients with and with-
out vascular reconstruction at discharge were 1.2±
0.2mg/dL and 1.4±0.2mg/dL, respectively (p=not
significant).
Long-term graft function: Mean recipient se-
rum creatinine levels were 1.3±0.1mg/dL at 1 year,
1.4 ± 0.1 mg/dL at 2 years, and 1.3 ± 0.2 mg/dL at
3 years postoperatively. There were two (4.4%)
recipient deaths. One died of intra-abdominal 
abscess with sepsis 3 months postoperatively.
The other died from intracranial hemorrhage, with
a functional graft, 15 months postoperatively.
Graft function continues in 41 of the remaining
43 harvested kidneys (95.3%).
Recipient complications
Three (6.7%) recipients had ureteral complica-
tions. Two anastomosis leaks occurred secondary
to harvest technique and were successfully man-
aged conservatively. One ureteral necrosis, thought
to be caused primarily by impaired vascularity of
the ureter, was managed by surgical revision of
ureteroneocystostomy. No patients developed
vascular thrombosis following transplantation.
Trends in donor/recipient outcome
Comparison between the earlier and later groups
with regard to both donor and recipient outcome
is shown in Table 3. Mean donor operative time
in the earlier and later group was 344.2 ± 17.0
minutes and 315.8 ± 12.3 minutes, respectively.
The mean estimated blood loss was 300.0±83.9 mL
and 276.0±58.6 mL, respectively. The mean warm
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Table 3. Trends in donor and recipient outcome between earlier and later groups in the laparoscopic donor
nephrectomy series*
Earlier group Later group Overall 
(cases 1–20) (cases 21–45) (cases 1–45)
Donor
Age (yr) 44.6 ± 3.4 41.1 ± 2.5 42.7 ± 2.1
Gender (M:F) 5:15 14:11 19:26
Body height (cm) 159.1 ± 2.0 164.2 ± 1.9 161.9 ± 1.4
Body weight (kg) 61.1 ± 2.9 66.4 ± 2.2 64.0 ± 1.8
Body mass index 24.0 ± 0.8 24.5 ± 0.6 24.3 ± 0.5
Operative time (min) 344.2 ± 17.0 315.8 ± 12.3 327.7 ± 10.2
Blood loss (mL) 300.0 ± 83.9 276.0 ± 58.6 286.0 ± 48.3
Warm ischemia time (s) 321.0 ± 39.9 177.0 ± 6.2† 233.9 ± 19.6
Postoperative stay (d) 6.3 ± 0.3 5.4 ± 0.2 5.8 ± 0.2
Serum Cr (discharge) (mg/dL) 1.1 ± 0.1 1.3 ± 0.1 1.2 ± 0.0
Serum Cr ratio (discharge/admission) 1.5 ± 0.0 1.5 ± 0.0 1.5 ± 0.0
Intraoperative complications 3 (15) 0 (0)† 3 (6.7)
Postoperative complications 4 (20) 4 (16) 8 (17.8)
Recipient
Serum Cr (1 wk) (mg/dL) 1.9 ± 0.4 1.8 ± 0.3 1.9 ± 0.2
Serum Cr (discharge) (mg/dL) 1.5 ± 0.3 1.2 ± 0.1 1.4 ± 0.1
Serum Cr (1 yr) (mg/dL) 1.3 ± 0.1 1.3 ± 0.0 1.3 ± 0.1
*Data presented as mean± standard error of the mean or n or n (%); †p<0.05 compared with earlier group by unpaired Student’s t test.
ischemia time was 321.0 ± 39.9 seconds and
177.0 ± 6.2 seconds, respectively. There was a sig-
nificant decrease in warm ischemia time in the
later group (p = 0.01). The mean donor postoper-
ative stay was 6.3 ± 0.3 days and 5.4 ± 0.2 days,
respectively. The mean donor serum creatinine
level at discharge was 1.1 ± 0.1 mg/dL and 1.3 ±
0.1 mg/dL, respectively. The donor serum creati-
nine discharge/admission ratio was the same 
in both groups. There was a significant decline in
the rate of donor intraoperative complications in
the later group (p = 0.00). The mean recipient
serum creatinine level at 1 week postoperatively
was 1.9 ± 0.4 mg/dL and 1.8 ± 0.3 mg/dL, respec-
tively. The mean recipient serum creatinine level
at discharge was 1.5 ± 0.3 mg/dL and 1.2 ± 0.1 mg/
dL, respectively. The mean recipient serum creati-
nine level at 1 year postoperatively was 1.3 ±
0.1 mg/dL and 1.3 ± 0.0 mg/dL, respectively. There
was no significant difference between earlier and
later groups with regard to postoperative donor
and recipient serum creatinine levels.
Comparison between LDN and ODN
Comparison between the LDN and ODN series
with regard to donor and recipient outcome is
shown in Table 4. Mean donor operative time in
the LDN and ODN series was 327.7±10.2 minutes
and 246.3 ± 24.4 minutes, respectively. The mean
estimated blood loss was 286.0 ± 48.3 mL and
268.2 ± 38.9 mL, respectively. The mean donor
postoperative stay was 5.8 ± 0.2 days and 10.3 ±
1.1 days, respectively. There was a significant 
decrease in donor postoperative stay in the LDN
series (p=0.00). The mean donor serum creatinine
level at discharge was the same in both series. The
donor serum creatinine discharge/admission ratio
was 1.5 ± 0.0 and 1.4 ± 0.1 in the LDN and ODN
series, respectively. There was no significant differ-
ence in donor intraoperative and postoperative
complications between both series. The mean re-
cipient serum creatinine level at 1 week postop-
eratively was 1.9 ± 0.2 mg/dL and 2.2 ± 0.3 mg/dL
in the LDN and ODN series, respectively. The mean
recipient serum creatinine level at discharge was
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Table 4. Comparison between the laparoscopic donor nephrectomy (LDN) and open donor nephrectomy
(ODN) series with regard to both donor and recipient outcomes*
LDN (n = 45) ODN (n = 12)
Donor
Age (yr) 42.7 ± 2.1 48.8 ± 3.4
Gender (M:F) 19:26 4:8
Body height (cm) 161.9 ± 1.4 161.5 ± 2.7
Body weight (kg) 64.0 ± 1.8 65.6 ± 4.3
Body mass index 24.3 ± 0.5 25.0 ± 1.0
Operative time (min) 327.7 ± 10.2 246.3 ± 24.4
Blood loss (mL) 286.0 ± 48.3 268.2 ± 38.9
Postoperative stay (d) 5.8 ± 0.2† 10.3 ± 1.1
Serum Cr (discharge) (mg/dL) 1.2 ± 0.0 1.2 ± 0.1
Serum Cr ratio (discharge/admission) 1.5 ± 0.0 1.4 ± 0.1
Intraoperative complications 3 (6.7) 1 (8.3)
Postoperative complications 8 (17.8) 2 (16.6)
Recipient
Serum Cr (1 wk) (mg/dL) 1.9 ± 0.2 2.2 ± 0.3
Serum Cr (discharge) (mg/dL) 1.4 ± 0.1 1.6 ± 0.2
Serum Cr (1 yr) (mg/dL) 1.3 ± 0.1 1.6 ± 0.2
Serum Cr (2 yr) (mg/dL) 1.4 ± 0.1 1.5 ± 0.2
Serum Cr (3 yr) (mg/dL) 1.3 ± 0.2 1.4 ± 0.2
*Data presented as mean± standard error of the mean or n or n (%); †p<0.05 compared with the ODN series by unpaired Student’s t test.
1.4 ± 0.1 mg/dL and 1.6 ± 0.2 mg/dL, respectively.
The mean recipient serum creatinine level was
1.3±0.1 mg/dL and 1.6±0.2 mg/dL at 1 year, 1.4±
0.1 mg/dL and 1.5±0.2 mg/dL at 2 years, and 1.3±
0.2 mg/dL and 1.4 ± 0.2 mg/dL at 3 years postop-
eratively. There was no significant difference be-
tween the LDN and ODN series with regard to
immediate and long-term allograft function.
Discussion
Living kidney donation offers an alternative for
individuals awaiting transplantation. It is the pre-
dominant source of organs in some developing
and developed countries, for example, Egypt and
Japan, for legal and cultural reasons.11,21 At many
centers in the United States, approximately 50%
of the kidney transplantations performed today
are from living donors. In Taiwan, about 30% of
the kidney transplantations performed are now
from living donors.
With the introduction of LDN, the number of
living kidney donors has increased significantly
during the past decade. Living kidney donation
in the United States, for example, increased from
3668 cases in 1996 to 6563 in 2005.22 Some stud-
ies have revealed that most donors have a positive
attitude to the LDN procedures.14,23
Living donor nephrectomy is a unique major
surgical procedure because it exposes an other-
wise healthy patient to the risks of major opera-
tion entirely for the benefit of recipients. The steep
learning curve of LDN is well known from the ex-
perience of institutions with large volumes of pa-
tients. Although LDN appears to be relatively low
risk for the donor, there are anecdotal and pub-
lished reports of death attributed to living kidney
donation.24 In a survey of 234 renal transplant pro-
grams, Matas et al found two donor deaths and one
case of persistent vegetative state, all from hem-
orrhagic shock, among 10,828 cases.25 Therefore,
donor safety should be the first priority when 
developing LDN techniques.
The mean operative time in our LDN series
was longer than those in the previous series.5,6,8,9
A mean operative time of 202.1 ± 52.4 minutes
in the Maryland series, 252.9 ± 55.7 minutes in
the Johns Hopkins series, 196 ± 43 minutes in
the UCSF series, and 208.2 ± 55.6 minutes in the
Mount Sinai series have been reported. From the
experience of the UCSF and Mount Sinai series,
the operative time did decrease with experience.8,9
There was also a trend towards a decrease in mean
operative time in our later group, although the dif-
ference was not significant. We expect to keep 
decreasing the operative time as our experience
increases. Our series had comparable results with
previous series with regard to blood loss and warm
ischemia time.5–7,9 The mean blood loss was 128±
194mL in the Maryland series, 344.2±690.3mL in
the Johns Hopkins series, 197 ± 223.0 mL in the
Mount Sinai series, and 286.0 ± 48.3 mL in our se-
ries. The mean warm ischemia time was 169±90.8
seconds in the Maryland series, 4.9 ± 3.4 minutes
in the Johns Hopkins series, 2.6 ± 0.5 minutes in
the Northwestern series, 207.0 ± 91.6 seconds in
the Mount Sinai series, and 233.9 ± 19.6 seconds
in our series. There was a significant decrease in
mean warm ischemia time in our later group. How-
ever, warm ischemia time did not correlate with
incidence of delayed graft function or recipient
serum creatinine levels at any postoperative time
in our series, which was similar to the findings of
the other series.26,27
LDN is quite challenging in obese donors, who
most benefit from the procedure with regard to
wound and pulmonary complications. There are
cumulative data in the literature indicating that
LDN can be performed safely in obese donors.28
In our series, 25 donors (55.6%) had BMI>24 and
eight (17.8%) had BMI > 27. Although operation
on obese donors certainly increases the stress on
the surgeon, it did not take longer operative time,
increase operative complications, or need any
technical modifications in our series.
Three-dimensional computed tomographic an-
giography was routinely performed on all our do-
nors preoperatively to help identify renal vascular
anatomy, including the number of main renal ves-
sels, presence of branches of renal vessels, and the
relationship between each vessel. In our series,
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11.1% of the donors had multiple renal arteries,
in contrast to 17% in the UCSF series and 23% in
the Northwestern series.7,8 The higher rate of mul-
tiple renal arteries in the Northwestern series may
have been caused by the higher rate (99%) of left
donor nephrectomy in that series. Two (40%) of
the cases with multiple renal arteries in our series
were identified preoperatively and three (60%)
were identified intraoperatively. We took every ef-
fort to preserve all branches, no matter whether
they were main or polar branches. There was a sig-
nificant increase in intraoperative blood loss in
the group with multiple renal arteries. Operative
time and warm ischemic time were longer in the
multiple renal arteries group, although there was
no significant difference. Another three cases re-
sulted from the application of the vascular stapler
to a renal artery with early bifurcation. We found
that this was most likely to arise if the bifurcation
was <1 cm from the aorta junction. Overall, 17.8%
of donor kidneys required bench arterial recon-
struction by end-to-side anastomosis or double-
barrel anastomosis. Kidneys that required vascular
reconstruction experienced similar allograft out-
comes, both immediate and long-term, to those
without reconstruction.
It has been reported that right LDN has a higher
rate of delayed graft function and vascular throm-
bosis caused by a short renal vein, and several
groups have avoided or abandoned the perform-
ance of this procedure.29,30 With improved tech-
nique and increasing experience, right LDN can be
performed safely with excellent graft outcomes
and low donor morbidity.31–33 Left donor nephrec-
tomies were performed in 96% of donors in the
Maryland series, 95% in the Johns Hopkins series,
99% in the Northwestern series, 84% in the UCSF
series, 86% in the Mount Sinai series, and 91% in
our series.5–9 With more experience, right LDN and
donors with complex renal vessels can be managed
with fewer complications. Some centers prefer to
choose the right kidney when vascular anomalies
are present in the left kidney, and accept the shorter
length of the right renal vein. Other centers pre-
fer to choose the left kidney and reconstruct mul-
tiple vessels for implantation. We selected the side
of nephrectomy based on the same criteria used
in open operation, which is similar to the experi-
ence of the UCSF and Mount Sinai series.8,9 There
was also no significant difference in donor oper-
ative time, blood loss, warm ischemia time, post-
operative stay, and complications between our
right-sided and left-sided groups (Table 2).
The occurrence of major vascular complica-
tions that require conversion to open surgery is
unique to the laparoscopic approach. Such com-
plications are more readily managed during the
open approach and may not always be reported.
Our experience is similar to those of previous se-
ries; most open conversions are the result of reno-
vascular injuries and happen in the earlier period.
Three renal vein injuries occurred in our earlier
group and two were caused by overtraction. We
used to place vessel loops around each major ves-
sel to facilitate traction during hilum dissection
and help identify the vessels during posterior dis-
section of the kidney. However, forced traction
leads to disruption of the lumbar veins and, finally,
open conversion. This was discovered by postop-
erative video review and did not happen again in
our later group after applying gentle traction of
vessel loops.
One of the major reasons for renovascular in-
juries is device failure and misapplication, which
may lead to catastrophic bleeding and poten-
tially donor death.34 We adopted the UCSF meth-
od to manage the renal vessels: the renal artery was
occluded using a locking plastic clip and a metal
endoclip, and the renal vein was stapled using an
Endo-TA stapler. These techniques essentially
separate vessel occlusion and vessel transection,
which allows careful visualization of the arterial
and venous ligation before transection. An added
benefit of this technique is to obtain additional
vessel length with fewer staple lines than with
the GIA (gastrointestinal anastomosis) stapler.
Using these methods, we did not experience any
significant bleeding caused by device failure and
misapplication.
Bowel complications have also been reported
during the laparoscopic approach. In the Maryland
series, five small bowel obstructions were reported
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that required laparotomy.6 In the Johns Hopkins
series, there were five bowel injuries, including one
duodenal injury, three small bowel injuries, and
one colon injury.5 In the UCSF series, there were
two small bowel injuries and one bladder injury.8
We did not observe any bowel complications in
our series. To avoid the risk of bowel injuries dur-
ing laparoscopic dissection, direct manipulation
of the bowel should be minimized and blunt in-
strumentation should be used for retraction. It is
also important to be well aware of the anatomy
during dissection of renocolic and renosplenic
planes, in order not to create mesocolic defects,
and splenic and pancreatic injuries.
Chylous ascites is a potential complication of
LDN because of dissection and division of the lym-
phatics adjacent to the renal hilum. We began to
notice chylous ascites in the middle period of our
series. Increasing experience encouraged us to do
more extensive dissection and to acquire maximal
vessel length, which contributed to this complica-
tion. Thereafter, we modified our technique to a
less extensive but adequate dissection and have
not observed such complications again.
The Maryland series reported that donor mean
postoperative serum creatinine level was 1.5 times
higher than the preoperative level.6 The North-
western series reported that the donor preopera-
tive and postoperative day 7 serum creatinine
levels were 0.9 ± 0.2 mg/dL and 1.3 ± 0.3 mg/dL,
respectively.7 Our series had a similar result in that
the preoperative and postoperative donor serum
creatinine levels were 0.8 ± 0.0 mg/dL and 1.2 ±
0.0 mg/dL, respectively. The donor postoperative/
preoperative serum creatinine ratio was 1.5 ± 0.0.
Graft function and recipient survival should
be taken into consideration when assessing this
innovative laparoscopic technique. The Maryland
series reported that recipient serum creatinine
level averaged 2.0±1.5 mg/mL at 1 week and 1.7±
1.1 mg/mL at 1 month postoperatively.6 However,
13.3% of recipients did not achieve a serum creati-
nine level of <3.0 mg/mL within 7 days. The Johns
Hopkins series reported that recipient serum cre-
atinine level averaged 2.6 ± 2.3 mg/dL at 4 days
after operation, which is similar to that in the
open group.5 The Northwestern series reported
that recipient serum creatinine level averaged 1.5±
0.2 mg/dL at 1 week.7 The Mount Sinai series re-
ported 3.0% delayed graft function and 2.5% graft
loss.9 In our series, recipient serum creatinine level
averaged 1.9±0.2 mg/dL at 1 week postoperatively
and 1.4±0.1mg/dL at discharge. Primary nonfunc-
tion of the renal allograft did not occur and de-
layed graft function occurred in four of 45 cases
(8.9%). All but one patient was discharged with ad-
equate renal function. No recipient death occurred
in the immediate postoperative period. With re-
gard to immediate graft function, we had compa-
rable results to those of the previous series.5–7,9
The Maryland series reported that recipient se-
rum creatinine level averaged 1.6 ± 1.4 mg/mL at
1 year, 1.9 ± 1.4 mg/mL at 2 years, 1.7 ± 1.0 mg/mL
at 3 years, and 1.7 ± 0.7 mg/mL at 4 years.6 The
Johns Hopkins series reported that recipient cre-
atinine clearance averaged 65.5 ± 25.8 mL/min 
at 5 years, which was similar to that in the open
group.5 The Northwestern series reported that graft
function continued in 481/500 (96%) kidneys
during follow-up.7 In our series, recipient serum
creatinine level averaged 1.3 ± 0.1 mg/dL at 1 year,
1.4 ± 0.1 mg/dL at 2 years, and 1.3 ± 0.2 mg/dL at
3 years. Graft function continued in 41 of the 43
harvested kidneys (95.3%). With regard to long-
term graft function, we also had comparable re-
sults to those of the previous series.5–7
Previous studies have shown a significantly
higher rate of ureteral complications in transplant
recipients with the laparoscopic approach in early
experience.5 With evolution of the ureteral dissec-
tion technique, this problem seems to have been
solved. In our current technique, soft tissue around
the ureter was preserved as much as possible in
order not to injure the blood supply of the ureter.
We clipped and transected the gonadal vein at the
level of ureter division. We routinely stented the
ureter in the recipient operation and removed it
1 week later. The Maryland series reported 33/730
(4.5%) cases of ureteral necrosis/ischemia, the
Johns Hopkins series reported 24/381 (6.3%)
ureteral complications, and the Northwestern 
series reported only 1/500 (0.2%) patients with
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ureteral stricture.5–7 In our series, 3/45 (6.7%) re-
cipients had ureteral complications and only one
(2.2%) had ureteral necrosis that was thought to
be caused by the laparoscopic procedure. With
regard to ureteral complications, we had compa-
rable results to those of the previous series.5–7
Technical-related vascular thrombosis is another
serious complication that can result in graft loss.
The Johns Hopkins series reported 8/381 (2.1%)
cases of vascular thrombosis, and the Northwest-
ern series reported 4/500 (0.8%) recipients with
vascular complications, including two with renal
artery thrombosis.5,7 We did not have any cases of
vascular thrombosis and attributed this to rou-
tine systemic heparinization before division of
renal vessels.
The UCSF series reported a significant decrease
in operative time with experience.8 The Johns
Hopkins series reported a significant decline in
total donor complications, ureteral complications,
allograft loss, and vascular thrombosis with increas-
ing experience.5 With more experience and spe-
cific evolution in surgical techniques, we achieved
a significant reduction in donor intraoperative
complications and warm ischemia time in the later
group. Although there were no significant differ-
ences, the operative time, estimated blood loss and
donor postoperative complications also declined
in the later group. The most likely explanation for
these observations is the steep learning curve for
LDN, which requires a greater number of patients
to reveal the progress made.
A few randomized studies have compared LDN
and ODN.35–37 Øyen et al concluded that despite
ODN being a very secure procedure regarding do-
nor safety, a perfect, uncomplicated LDN appears
to be the superior procedure.37 The equivalent
renal graft function between LDN and ODN has
also been documented.38,39 In our series, the op-
erative time in the LDN series was longer than that
in the ODN series, although there was no signifi-
cant difference. The LDN series had a significantly
shorter donor postoperative stay than that in the
ODN series, as expected. Both series had equiva-
lent results with regard to donor safety, donor
outcome, and immediate and long-term allograft
function. Before 2002, we had only 12 living kid-
ney donors who received ODN in 12 years (1990–
2001). The number of living kidney donors 
increased significantly after we adopted and devel-
oped LDN after 2002 (45 cases, 2002–2007). The
percentage of living/all kidney donations in our
center increased from 13.5% before 2002 to 56.5%
after 2002. In these years, the percentage of living
kidney donation in Taiwan was around 30%. From
our experience, it is expected that the number of
living kidney donations will keep growing with
the popularization of LDN.
In conclusion, the number of living kidney
donations increased significantly after adopting
LDN in our series. An equivalent donor/recipient
outcome in the LDN series to that in the previ-
ously reported series and our ODN series was
achieved with increasing experience.
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